In order to help consumers decide on which sunscreen to buy and how to use it, the Food and Drug Administration (FDA) has announced new regulations and changes for the labeling and marketing of over-the-counter (OTC) sunscreens.
The new regulations include:
- Standards for testing effectiveness of sunscreen products and labeling according to test results;
- Limiting the maximum SPF value to “SPF 50+” on sunscreen labels;
- A data request for effectiveness and safety information for sunscreen products formulated in specific dosage forms, such as sprays;
- Guidance for manufacturers of sunscreen products on appropriate testing and labeling in accordance with new regulations.
According to an official in the FDA’s Division of Nonprescription Regulation Development, these new measures are necessary in light of the importance for consumers to clearly understand the differences between sunscreen products. The new regulations, effective in one year, will also establish standards for sunscreens that can be labeled as “Broad Spectrum.” It is reported that any sunscreen that is not labeled as “Broad Spectrum” or has an SPF between 2 and 14 only helps prevent sunburn and does not protect against the risk of skin cancer or early signs of aging.
Manufacturers of consumer products need to properly test, label and market their products for the benefit of the consumer. A misrepresented product can be as dangerous as a defective one.
If you or a loved one has suffered injury or illness due to an unsafe, defective, or misrepresented over-the-counter product in New Jersey, the experienced New Jersey product liability lawyers at Blume Forte can help you determine whether you may have a valid claim to pursue compensation. Call us for a no-cost consultation at 973-635-5400.